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Senescence is a form of cell cycle arrest induced by stress such as DNA damage and oncogenes. However, while
arrested, senescent cells secrete a variety of proteins collectively known as the senescence-associated secretory
phenotype (SASP), which can reinforce the arrest and induce senescence in a paracrine manner. However, the SASP
has also been shown to favor embryonic development, wound healing, and even tumor growth, suggesting more
complex physiological roles than currently understood. Here we uncover timely new functions of the SASP in
promoting a proregenerative response through the induction of cell plasticity and stemness. We show that primary
mouse keratinocytes transiently exposed to the SASP exhibit increased expression of stem cell markers and re-
generative capacity in vivo. However, prolonged exposure to the SASP causes a subsequent cell-intrinsic senescence
arrest to counter the continued regenerative stimuli. Finally, by inducing senescence in single cells in vivo in the
liver, we demonstrate that this activates tissue-specific expression of stem cell markers. Together, this work un-
covers a primary and beneficial role for the SASP in promoting cell plasticity and tissue regeneration and introduces
the concept that transient therapeutic delivery of senescent cells could be harnessed to drive tissue regeneration.
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Cellular senescence can be induced by a variety of stress
stimuli. These can include active oncogene signaling,
DNA damage, irradiation, or chemotherapy, causing the
activation of tumor suppressor networks, including p53,
p16 (Cdkn2a), and p21 (Cdkn1a), and cell cycle arrest (Ser-
rano et al. 1997; Schmitt et al. 2002; Coppe et al. 2008;
Campisi 2013). Thereby, senescence acts as a cell-intrin-
sic tumor-suppressive mechanism that prevents the pro-
liferation of damaged cells. However, senescence can
also contribute to tumor suppression in a cell-extrinsic
manner through senescence-associated secretory pheno-
type (SASP)-mediated recruitment of immune cells
(Kang et al. 2011; Lujambio et al. 2013).
Cellular senescence is also induced upon replicative ag-
ing of cells in culture, and senescent cells accumulate in
multiple tissues and stem cells during physiological aging
(Dimri et al. 1995; Baker et al. 2016). This accumulation of
nonproliferating cells contributes to the loss of functional
and regenerative capacity in aged tissues, preventing pro-
liferation of both somatic and stem cells in a cell-intrinsic
manner (Janzen et al. 2006; Krishnamurthy et al. 2006;
Molofsky et al. 2006; Sharpless and DePinho 2007; Sou-
sa-Victor et al. 2014; Baker et al. 2016; Garcia-Prat et al.
2016). Additionally, senescent cells can contribute to
loss of tissue function during aging through non-cell-au-
tonomous mechanisms. This can result from SASP pro-
teins disrupting homeostasis or possibly through the
induction of paracrine senescence in neighboring cells
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(Baker et al. 2011; Acosta et al. 2013; Campisi 2013).
Therefore, this supports how aging and decreased regener-
ation may in part result from senescence and tumor-sup-
pressive mechanisms.
Recently, however, beneficial roles for senescence have
been emerging, often mediated through the SASP. In the
developing embryo, senescent cells are suggested to con-
tribute to tissue development and patterning through
both remodeling mediated by senescent cell clearance
and tissue growth and patterning through the SASP (Mu-
noz-Espin et al. 2013; Storer et al. 2013). In addition, sen-
escent cells recruit immune cells and limit fibrosis during
wound healing and contribute to wound repair through
the secretion of growth factors (Krizhanovsky et al.
2008; Jun and Lau 2010; Demaria et al. 2014). However,
these same beneficial effects on tissue growth and pattern-
ing can have unwanted side effects through promoting tu-
mor growth and progression (Krtolica et al. 2001;
Yoshimoto et al. 2013).
Reconciling these beneficial and detrimental aspects
of the senescence program has been difficult. Here, we
describe how transient exposure to the SASP can promote
tissue regeneration. However, prolonged exposure leads to
a subsequent cell-intrinsic arrest, likely as a tumor-sup-
pressive response to aberrant regeneration. This work un-
covers important mechanistic insights into the biological
function of senescence.
Results
To explore the senescence program in epithelial cells, we
performed microarray analysis on primary mouse kerati-
nocytes undergoing oncogene-induced senescence (OIS)
from the expression of oncogenic HRasV12. As expected,
senescent keratinocytes exhibited hallmark features of
senescence, including decreased proliferation, a large flat
appearance, increased senescence-associated β-galactosi-
dase (SA-β-Gal) activity, and increased expression of p53,
p21, and p16 (Supplemental Fig. 1a–d). Analysis of the mi-
croarray signature revealed that other knownmediators of
senescence and the SASP were also increased, including
p15 (Cdkn2b), Il1a, and Hmga2 (Fig. 1A). Surprisingly,
however, senescent cells also exhibited increased expres-
sion of many genes normally associated with somatic
and cancer stem cells, including CD34, Lgr6, Prom1,
CD44, Ngfr, and Nestin (Fig. 1A). This was further sup-
ported by bioinformatics and gene set enrichment analy-
sis (GSEA) using Genomatix software and published
signatures of common stem cell populations (Fig. 1B,C;
for full gene lists, see Supplemental Table 1; Blanpain
et al. 2004). To validate this signature, we performed
quantitative PCR (qPCR) analysis for selected skin stem
cell genes in senescent cells up to 2 wk after infection
(Fig. 1D). As before, we found increased expression of
many of these, including CD34, Nestin, Lrig1, and Lgr6
as well as other hair follicle stem cell (HFSC) genes
(Supplemental Fig. 1f). Similar observations were also no-
ticed in the primary control cells, which undergo senes-
cence-like changes upon prolonged culture, including
adopting a senescent-like morphology and exhibiting
increased expression of p16 (Supplemental Fig. 1e,h).
Surprisingly, these cells also displayed an increase in the
same stem cell genes, although at lower levels than
seen in OIS (Supplemental Fig. 1e,g). Supporting the unan-
ticipated link between senescence and stemness, when
senescence was induced in additional ways, including
treatment of cells with the chemotherapeutic drug etopo-
side or irradiation, the cells also displayed an increase in
the same stem cell genes while undergoing senescence
(Fig. 1E–F).
Furthermore, in agreement with the transcript profile,
upon OIS induction, we found a significant increase in
the number of newborn keratinocytes that were double-
positive for CD34 and integrin-α6 proteins, which label
a distinct population of HFSCs (Fig. 2A; Supplemental
Fig. 2a; Blanpain et al. 2004; Jensen et al. 2010). Interest-
ingly, newborn keratinocytes do not yet express these
stem cell markers, which become expressed after estab-
lishment of the hair cycle in the adult, suggesting that
these markers are being induced de novo during senes-
cence induction (Supplemental Fig. 2b–d). Remarkably,
however, even though there was an increase in stem-
ness-associated markers, these cells were still undergoing
proliferative arrest, as measured by a progressive decrease
in proliferation (Supplemental Fig. 1c) and a loss of clono-
genic capacity in the total (Fig. 2B,C) and double-positive
CD34/integrin-α6 cells (Fig. 2D; Supplemental Fig. 2e). In-
deed, qPCR analysis on the double-positive CD34/integ-
rin-α6 population showed that these cells were not
escaping senescence but expressed high levels of the sen-
escence markers p16 and p21 (Fig. 2E; Supplemental Fig.
2f). Together, these results demonstrate that senescent
cells, while undergoing senescence arrest and loss of clo-
nogenicity, paradoxically exhibit increased markers nor-
mally associated with stemness.
To investigate this unexpected connection between
senescence and stem cells in vivo, we explored the inci-
dence and distribution of senescence in papillomas that
were induced with DMBA/TPA treatment, an in vivo
model of OIS. Upon examination of established papillo-
mas for SA-β-Gal activity, no staining was detectable in
the epithelial layers of the tumor, with the strongest reac-
tivity found in the underlying dermal tissue and some re-
gions of the papilloma stroma (Fig. 3A–H). However, a
thorough analysis of the expression patterns of known
senescence markers—including p16, p21, p19, p53,
γH2AX, and Ki67—by immunohistochemistry demon-
strated high expression of these proteins in the epithelial
cells and the underlying dermis, with a more diffuse ex-
pression in the stroma of the benign lesion (Fig. 3I–K,
Supplemental Fig. 3a–c). Papilloma arises from the aber-
rant upward expansion and differentiation of CD34+
stem cells in the basal and early differentiating layers of
the epithelial papilloma (Fig. 3L; Malanchi et al. 2008;
Lapouge et al. 2012). Detailed quantification of the distri-
bution of the senescencemarkers revealed that thesewere
most highly expressed in these same stem cell layers
(Fig. 3M; Supplemental Fig. 3d). Interestingly, the basal-
initiating layer of the papilloma contained cells that
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were positive for both proliferation markers (such as
Ki67 or PCNA) and senescence markers, suggesting a dy-
namic process of aberrant proliferation and subsequent ar-
rest (Supplemental Fig. 3g–i). Given this result, we
extended our analysis to another model of in vivo OIS in
the pancreas, where activation ofmutant KRasG12D drives
senescence and premalignant pancreatic intraepithelial
neoplasia (PanIN) lesions (Morton et al. 2010). Detailed
histological analysis of these tissues revealed increased
expression of senescence markers, including SA-β-Gal,
p21, and p53, concomitant with deceased proliferation
(Supplemental Fig. 4). Interestingly, here also there was
increased activation of the stem cell markers CD44
and Nestin in these senescent lesions. Altogether, this
Figure 1. Astemcell signature is increased in senescent cells. (A) Representativeheatmapofmicroarrayanalysis ofHRasV12-induced sen-
escent keratinocytes compared with growing keratinocytes. Example genes are shown to illustrate that stem cell and senescent genes are
more highly expressed in senescent cells compared with growing cells. (B) Bioinformatics analysis of genes significantly up-regulated in
senescent cells (analysis performed using Genomatix software; full list of up-regulated and down-regulated genes is in Supplemental
Table 1). (C ) GSEA of stem cell genes (Blanpain et al. 2004) in the gene expression profile of Ras-induced senescent keratinocytes. (NES)
Normalized enrichment score. (D) qPCR analysis for skin stem cell and senescence genes in Ras-infected keratinocytes at 4–14 d post-in-
fection (dpi) normalized to vector-infected keratinocytes at 4 dpi. n = 4, except for 14 dpi (n = 3). (E) qPCR analysis of etoposide-treated ker-
atinocytes 3–5 d after treatment normalized to DMSO-treated keratinocytes 3 d after treatment. n = 5, except for day 5 (n = 3). (F ) qPCR
analysis of irradiated keratinocytes (12 Gy) 5 and 10 d after irradiation normalized to keratinocytes before irradiation. n = 2. (D–F ) Error
bars indicate mean ± SEM. (∗) P < 0.05; (∗∗) P < 0.01; (∗∗∗) P < 0.001), two-tailed Student’s t-test.
Senescence induces tissue regeneration
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demonstrates that also in vivo in models of premalignant
lesions, there is a pronounced association of stem cell
markers in senescent cells.
To investigate whether cells that show increased ex-
pression of stem cell markers in culture while undergoing
senescence might be escapers from the senescence pro-
gram or function as stem cells, we used an in vivo assay
to assess the properties of these cells. To address this,
we performed skin grafting assays, a test of HFSC function
in which freshly isolated newborn keratinocytes or puri-
fied adult CD34+ HFSCs are grafted along with dermal fi-
broblasts into full-thickness wounds in the back of nude
mice (Blanpain et al. 2004; Jensen et al. 2010). This results
in large patches of hair follicles that develop directly from
the transplanted cells (Supplemental Fig. 5a), whereas if
the keratinocytes are placed in culture prior to transplan-
tation, they lose their regenerative capacity, generating
only pigmented scar tissue (Supplemental Fig. 5b). We in-
vestigated whether keratinocytes expressing theHRasV12
oncogene and increasing expression of the stem cellmark-
ers could function asHFSCs in vivo by transplantingGFP+
HRasV12-infected keratinocytes undergoing senescence.
Remarkably, this resulted in the generation of a papilloma
that was histologically and molecularly similar to the
DMBA/TPA ones, including exhibiting similar patterns
of senescence protein expression in the epithelial layers
as well as possessing an aberrant layer of CD34+ cells
(Supplemental Fig. 5c–j). Indeed, most of the papilloma
consisted of GFP+ senescent cells, suggesting that, even
in vivo, senescing cells with increased stem cell markers
remained senescent. Interestingly, however, while most
of the papilloma was GFP+ (likely arising from the prolif-
eration of not-fully senescent cells), it contained small re-
gions that were clearly negative for GFP, suggesting that
endogenous keratinocytes were being recruited into a pre-
malignant fate (Fig. 3N–Q).
Given this coexpression of senescence and stem cell
genes, we investigated whether these were functionally
linked. To address this, we assessed the expression of
these same stem cell genes upon disruption of key senes-
cence regulators—including cell cycle inhibitors p53, p16,
and p21—and SASP mediators NFKB, CEBPB, IL1A, and
Figure 2. OIS induces de novo specification of stem cell fate. (A) Representative FACS plots and quantification for α6-integrin+/CD34+
stem cells in Ras- or vector-infected keratinocytes at 7, 10, and 14 dpi. n = 3. (B,C ) Representative images of colony-forming assays of vec-
tor-infected keratinocytes at 7 dpi and Ras-infected keratinocytes at 7 and 14 dpi (B) and quantification of numbers of colonies of Ras-in-
fected keratinocytes at 7 and 14 dpi normalized to colonies of vector-infected keratinocytes at 7 dpi (C ). n = 5, except for 14 dpi (n = 3). (D)
Quantification of the numbers of colonies of sorted α6-integrin+/CD34+ cells fromRas-infected keratinocytes at 14 dpi normalized to col-
onies of sorted α6-integrin+/CD34+ cells from adult epidermis. n = 3. (E) qPCR analysis of sorted α6-integrin+/CD34− and α6-integrin+/
CD34+ from Ras-infected keratinocytes at 14 dpi normalized to vector-infected keratinocytes at 4 dpi. n = 2, except for CD34− (n = 3).
(A,C,D,E) Error bars indicate mean ± SEM (∗) P < 0.05; (∗∗) P < 0.01; (∗∗∗) P < 0.001, two-tailed Student’s t-test.
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p38. As expected, knockdown of the cell cycle inhibitors
now blocked the proliferation arrest and allowed senes-
cence bypass/proliferation. Surprisingly, however, loss of
these genes had little or no effect on the increased expres-
sion of the stem cell genes, which persisted after senes-
cence bypass either transiently (after p53 loss)
(Supplemental Fig. 6e) or long-term upon prolonged cul-
ture (after p16 or p21 loss) (Fig. 4A; Supplemental Fig.
6c,f). This is clearly seen in cells in which cell cycle inhib-
itor p16 was knocked down, as these retained high levels
of all of the analyzed stem cell genes, including CD34/
α6 integrin-positive cells, yet regained colony-forming ca-
pacity (Fig. 4B,C; Supplemental Fig. 6a–d).
Next, we investigated whether knockdown of the SASP
regulators affected stem cell gene expression. Interesting-
ly, here knockdown of RelA/NFKB caused a decrease in
the expression of many of the stem cells genes (Fig. 4D),
while loss of CEBPB, IL1A, and p38 had no effect
(Supplemental Fig. 7). This was further validated when
theNFKB pathwaywas inhibitedwith expression of a con-
stitutively activated repressor of the pathway (Fig. 4E). In
each instance, inhibition of the NFKB pathway had no ef-
fect on the senescence phenotype or proliferative arrest of
the cells (Supplemental Fig. 7a). Together, this suggests
that the senescence-associated increase in stem cell
gene expression is regulated in part by the NFKB-mediat-
ed arm of the SASP, while proliferation of cells expressing
aberrant activation of stem cell markers is blocked by tu-
mor suppressor genes.
Based on this, we functionally investigated whether
the SASP is linked to the increased expression of stem
cell genes. To investigate this hypothesis, we took
Figure 3. Senescent epithelial cells dis-
play a stemcell signature in vivo. (A) Hema-
toxylin and eosin (H&E) staining of DMBA/
TPA-induced papillomas. Boxed regions E
(epithelia), S (stroma), and D (dermis) are
representative of areas magnified in C–-
E. Bars, 50 µm. (B) SA-β-Gal staining of
papilloma. Boxed regions E (epithelia), S
(stroma), and D (dermis) are representative
of areas magnified in F–H. Bars, 50 µm. Im-
munohistochemistry for the senescence
markers p16 and p21 in the epithelia (I ),
stroma (J), and underlying dermis (K ) of
chemically induced papillomas. Bars, 25
µm. (L) Immunofluorescence for the epithe-
lial stem cell marker CD34 and DAPI in
chemically induced papillomas. (EPITH)
Epithelia; (STR) stroma. Bar, 25 µm. (M )
Distribution of senescence markers in
DMBA/TPA papillomas. All images are
representative of at least four biological rep-
licates. (N–Q) Nudemice were grafted with
a combination of 4 × 106 dermal fibroblasts
and 3 × 106 keratinocytes infected with ei-
ther vector at 6 dpi (N) or Ras at 6 dpi (O).
The number of mice is shown in the
bottom right corner. (P) Representative im-
munohistochemistry for GFP. (Q) Magnifi-
cation of the boxed region in P.
Senescence induces tissue regeneration
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conditioned medium (CM) from vector-infected growing
cells (VCM) or OIS keratinocytes (OIS-CM) and added it
to proliferating newborn primary mouse keratinocytes
(PMKs) during a short-term period (2 d) (Fig. 5A). Remark-
ably, transient exposure to OIS-CM led to a marked
increase in the same stem cell genes as before, demon-
strating that the SASP can induce stem cell gene expres-
sion (Fig. 5B). Additionally, when tested in colony-
forming assays, cells that had been transiently exposed
to the SASP exhibited increased clonogenic capacity
(Fig. 5C). Importantly, increased stem cell markers and
colony formation were also seen in cells that were treated
with CM from irradiation-induced senescent keratino-
cytes (Supplemental Fig. 8a). Next, we assessed whether
the SASP-treated cells possessed any functional properties
of stem cells in vivo. To examinewhether the SASP-treat-
ed cells possessed stem cell function, we transplanted
GFP+ cells that had been exposed to VCM or OIS-CM
into full-thickness grafts. As expected, the grafts contain-
ing keratinocytes treated with VCM healed over, present-
ing mostly with pigmented scar tissue and sparse
individual hair follicles (Fig. 5D,E). Remarkably, however,
the grafts containing cells that had been transiently treat-
edwithOIS-CMdeveloped large thick patches of hair (Fig.
5D,E). Importantly, staining of the grafts for GFP to trace
the transplanted cells confirmed that there was a signifi-
cant increase in the number of hair follicles following ex-
posure to the SASP and thatmost of the hair follicles were
coming from the SASP-treated GFP+ cells (Fig. 5F,G). This
demonstrates that the SASP can induce cellular plasticity
and stemness, promoting tissue regeneration.
As transient exposure to the SASP induces stemness
and regeneration, we asked whether longer exposure to
the SASP would amplify these properties. Accordingly,
PMK were treated with VCM or OIS-CM for longer time
periods. We found that the increased expression of HFSC
genes after a transient exposure to the SASP for 2 d was in-
creased further upon repeated exposure to the same SASP
for 6 d (Fig. 5H; Supplemental Fig. 8b). Interestingly, this
increased expression seemed to be dependent on the
SASP and not the length of time in culture, as removal
of the OIS-CM after 2 d resulted in restoration of base-
line levels of the stem cell genes (Supplemental Fig.
8c). Surprisingly, however, with repeated exposure, the
recipient cells now exhibited intrinsic features of senes-
cence, including proliferative decline and increased ex-
pression of p16 and SA-β-Gal (Fig. 5H–J), similar to
paracrine senescence induced upon long-term exposure
to the SASP (Acosta et al. 2013). Additional analysis
demonstrated that the CD34-positive cells now
Figure 4. Loss of SASP regulator NFκB in senescent cells causes a decrease in stem cell gene expression. (A) qPCR analysis of Ras- and
shp16 I-double-infected keratinocytes at 6, 10, and 14 dpi normalized to Ras- and vector-double-infected keratinocytes on the respective
days. n = 3. (B,C ) Representative colony-forming assay (B) and number of colonies (C ) of Ras- and vector-double-infected and Ras- and
shp16 II-double-infected keratinocytes at 14 dpi. n = 4. (D) qPCR analysis of Ras- and shRelA II-double-infected keratinocytes at 6, 10,
and 14 dpi normalized to Ras- and vector-double-infected keratinocytes on the respective days. n = 3. (E) The number of α6-integrin+/
CD34+ cells of Ras, shRelA I, shRelA II, and NFκB superrepressor (SR)-double-infected keratinocytes normalized to Ras- and vector-dou-
ble-infected keratinocytes at 10 dpi. n = 3. (A,C,D,E) Error bars indicate mean ± SEM. (∗) P < 0.05; (∗∗) P < 0.01; (∗∗∗) P < 0.001, two-tailed
Student’s t-test.
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expressed the cell cycle inhibitor p19 and that the entire
population was not apoptotic and had lost the ability to
form colonies in clonogenic assays (Supplemental Fig.
8d–f). This suggests that the intrinsic cell cycle arrest
of senescence may be activated as a tumor-suppressive
mechanism to block proliferation of cells with enhanced
plasticity.
Together, these data demonstrate that transient expo-
sure to the SASP can be beneficial in inducing cell plas-
ticity and regeneration, whereas prolonged exposure
could lead to paracrine and cell-intrinsic senescence ar-
rest. To find support for this in an in vivo setting, we ex-
amined a previously described model of transposon-
mediated intrahepatic gene transfer to stably deliver on-
cogenic Ras coexpressing GFP, which induces senes-
cence in single adult hepatocytes in murine livers
(Kang et al. 2011). These senescent cells are subse-
quently cleared by the immune system, while delivery
of an inactive effector loop mutant form of Ras that is in-
capable of signaling to downstream pathways fails to in-
duce senescence and circumvents the clearance. As
described, delivery of oncogenic NRasG12V caused induc-
tion of senescence markers in individual hepatocytes
(Fig. 6A; Supplemental Fig. 9a). When we examined the
surrounding tissue for previously described markers of
stem and cancer stem cells in the liver, we found in-
creased expression of CD44 in cells immediately adja-
cent to senescent cells, which was not seen in the
inactive Ras-expressing hepatocytes (Fig. 6B;
Supplemental Fig. 9b). While CD44 is a well-known
marker of cancer stem cells, here we cannot exclude
that it may also be labeling macrophages or other im-
mune cells. In addition, expression of oncogenic Ras
led to a dramatic increase in expression of Nestin in
the surrounding tissue, which was also absent from the
inactive control (Fig. 6C; Supplemental Fig. 9c). As Nes-
tin is also a well-described mediator of stemness and
plasticity in the liver (Tschaharganeh et al. 2014), this
Figure 5. Transient exposure to the SASP
induces stemcell function and tissue regen-
eration. (A) Scheme representing the strat-
egy used to collect VCM or OIS-CM and
subsequent treatment of freshly isolated
keratinocytes. (B) qPCR analysis for stem
cell and senescence genes on keratinocytes
treated for 48 h with VCM or OIS-CM. n =
10. (C ) Quantification of the numbers of
colonies of keratinocytes treated for 48 h
with VCM or OIS-CM. n = 4. (D,E) Repre-
sentative skin grafts in nude mice that
were grafted with a combination of 4 × 106
dermal fibroblasts and 6 × 106 keratinocytes
from the β-actin-GFP reporter mouse fol-
lowing 48 h of exposure to VCM or OIS-
CM. (F ) Representative immunohisto-
chemistry for GFP and DAPI on grafts in
D and E. (G) Graph showing the number
of hair follicles per field of view. Grafts
were analyzed 21–23 d after implantation.
n = 6 PMK+OIS-CM; n = 7 PMK+VCM.
(H) qPCR analysis for CD34 and p16 on ker-
atinocytes treated for 2–6 d with OIS-CM
normalized to VCM at day 2. n = 5, except
for OIS-CM day 6 (n = 4) and OIS-CM and
VCM day 2 (n = 10). (I ) Representative im-
ages of keratinocytes treated for 2, 4, and 6
d with VCM or OIS-CM. n = 5. Bars, 100
µm. (J) Quantification of SA-β-Gal-positive
cells of keratinocytes treated for 2–6 d
with VCM or OIS-CM. n = 4, except for
VCM day 6 (n = 3) and VCM and OIS-CM
day 4 (n = 2). (B,C,G,H,J) Error bars indicate
mean ± SEM. (∗) P < 0.05; (∗∗) P < 0.01; (∗∗∗)
P < 0.001, two-tailed Student’s t-test.
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further supports that the SASP can induce stem cell
properties in surrounding tissue.
Discussion
Collectively, our study uncovers a novel and fundamental
biological function of senescence and the SASP. We iden-
tified how transient exposure to the SASP can provide re-
generative signals that induce cell plasticity and
stemness, which are beneficial for tissue regeneration
(Fig. 7). However, prolonged or aberrant exposure to the
SASP subsequently provokes a cell-intrinsic senescence
block to these growth-promoting signals, resulting in
paracrine senescence responses and decreased regenera-
tive capacity (Fig. 7).
Altogether, these findings help to reconcile previously
described beneficial and detrimental attributes of senes-
cent cells. This study adds to the growing body of work
demonstrating beneficial roles for the SASP, including
during embryonic development (Munoz-Espin et al.
2013; Storer et al. 2013) and wound repair (Krizhanovsky
et al. 2008; Jun and Lau 2010; Demaria et al. 2014) through
a previously undescribed plasticity-inducing action.
Indeed, we propose a model in which senescent cells act
as niche-like signaling centers in which the damaged
cell prevents its own continued proliferation and produces
a SASP that activates the immune system to promote its
own clearance (Xue et al. 2007; Acosta et al. 2008; Kuil-
man et al. 2008; Kang et al. 2011). In addition, the senes-
cent cell produces extracellular matrix (ECM) and
growth factors to facilitate repair and growth (Coppe
et al. 2006; Krizhanovsky et al. 2008; Demaria et al.
2014), while, as we now describe, the SASP also induces
plasticity and stemness in neighboring cells, which can
replace the cleared senescent cell and promote tissue
regeneration. Therefore, in an unperturbed setting, this
would act beneficially to restore homeostasis and regener-
ation while eliminating damaged or aged cells.
However, when this process is perturbedwith excessive
accumulation or impaired clearance of senescent cells,
as is seen during aging and premalignant lesion forma-
tion, the consequences of aberrant senescence induction
become obvious and likely depend on the duration or
strength of the SASP exposure and the status of the target
cell. Indeed, when the clearance of senescent cells is per-
turbed, pronounced SASP exposure leads to tumor forma-
tion and progression (Krtolica et al. 2001; Kang et al.
2011; Rodier and Campisi 2011; Yoshimoto et al. 2013)
or paracrine senescence and aging (Baker et al. 2011;
Acosta et al. 2013).
Our study also suggests that paracrine senescence in-
duction by the SASP (Acosta et al. 2013) might include a
cell-intrinsic arrest to counter abnormal or prolonged re-
generative stimuli. In this case, the recipient cells likely
identify this extended regeneration as protumorigenic
Figure 6. Induction of senescence in single cells in liv-
ers induces an increase in stem cell markers in the sur-
rounding tissue of the liver. Representative histology
of liver sections 6 d after delivery of control (NrasG12V/
D38A-IRES-GFP) or mutant (NrasG12V-IRES-GFP) trans-
poson constructs. (A) H&E staining, immunohistochem-
istry for GFP and p21, and SA-β-Gal staining. Bars, 100
µm. (B,C ) Immunofluorescence for CD44, GFP, and
DAPI (B) and Nestin, GFP, and DAPI (C ). Bars, 50 µm.
All images are representative of at least three biological
replicates.
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and activate cell-intrinsic tumor-suppressive mecha-
nisms as a counteractive protection. This further supports
the theory that both the loss of the ability in mammals to
regenerate tissues and organs and the decline in tissue
function seen during aging might be the result of cell-in-
trinsic senescence and tumor suppression (Janzen et al.
2006; Krishnamurthy et al. 2006; Molofsky et al. 2006;
Sharpless and DePinho 2007; Sousa-Victor et al. 2014;
Garcia-Prat et al. 2016).
The SASP has also been shown to promote tumor for-
mation in a number of settings (Krtolica et al. 2001;
Kang et al. 2011; Rodier and Campisi 2011; Yoshimoto
et al. 2013). Our data develop these findings, suggesting
that NFKB-mediated SASP exposure might contribute to
plasticity during tumor formation through dedifferentia-
tion and amplification of the stem cell of origin, as has
been demonstrated previously in colon cancer models
(Myant et al. 2013; Schwitalla et al. 2013). In addition,
SASP effects could result in an expansion of stem cell
numbers, thereby increasing the likelihood that these
cells could acquire mutations or favor the induction of
cells to reside in a more plastic undefined state thatmight
be more susceptible to transformation (Tschaharganeh
et al. 2014; Varga et al. 2014). This could help explain
how senescence can favor tumor formation during aging,
and it will be interesting to determinewhether age-associ-
ated in vivo senescence has similar effects on plasticity
induction.
During tumor formation, dysregulation of tissue-specif-
ic stem cells often contributes to cancer stem cell proper-
ties. Our data support the notion that regenerative
attemptsmight promote de novo instruction of stem cells,
which could then progress to cancer stem cells upon
deregulation or mutation. For example, while CD34-posi-
tive cells are primary regulators of HFSCs in the skin, they
are also the cells of origin and tumor-propagating cells in
squamous cell carcinoma upon loss of p53-mediated ar-
rest (Lapouge et al. 2012). Additionally, Nestin is amarker
of stemcells inmany tissues, including the brain and skin,
yet aberrant activation of Nestin in liver tumors drives
cell plasticity and malignancy (Li et al. 2003; Toma
et al. 2005; Tschaharganeh et al. 2014; Neradil and Vesel-
ska 2015). Furthermore, while NFKB is a potent mediator
of age- and tumor-associated inflammation and dediffer-
entiation, it also contributes to HFSC regeneration upon
skin wounding (Chen et al. 2015) and is a key driver of
hair follicle initiation and development (Schmidt-Ullrich
et al. 2001; Zhang et al. 2009), further supporting how
NFKB-mediated processes regulating normal tissue devel-
opment and regeneration can contribute to tumor forma-
tion and cancer stem cell fate when misregulated (Myant
et al. 2013; Schwitalla et al. 2013). It is also interesting
here that cells that bypass senescence arrest through
knockdown of p16 still retain expression of the stem cell
signature and now exhibit increased clonal growth capac-
ity, suggesting that escape from senescence may lead to
more aggressive cancer stem cell properties mediated by
NFKB and a retained SASP. Indeed, this is supported by
previous studies demonstrating that cells that escape
from chemotherapy-induced senescence can acquire can-
cer stem cell properties (Achuthan et al. 2011).
This study also contributes to our understanding of the
role of senescence in papilloma and presents a tractable
model to study papilloma development independently of
the longer two-stageDMBA/TPA skin carcinogenesis pro-
tocol (Balmain et al. 1984; Kemp 2005; Abel et al. 2009).
Interestingly, the senescence-causing HRasV12 mutation
is induced in vivo with the DMBA/TPA procedure, which
develops from an aberrant expansion of CD34+ tissue
stem cells (Morris 2004; Malanchi et al. 2008; Abel et al.
2009; Lapouge et al. 2012). However, what causes the ac-
cumulation of stem cells and papilloma induction as
well as the potential contribution of senescent cells re-
main unclear. Our results suggest that papilloma forma-
tion in the DMBA-TPA model arises through multiple
events. Keratinocytes harboring the mutation can clonal-
ly amplify and produce a SASP that enhances stemness in
neighboring keratinocytes while progressing to become
terminally differentiated and senescent. However, simul-
taneously, there is a pronounced induction of senescence
in the dermal fibroblasts, suggesting that the SASP from
these cells might also contribute to the dedifferentiation
and amplification of the overlying keratinocyte stem
cells. While papilloma has been described as an in vivo
model of senescence, it was unexpected that the epithelial
keratinocytes would not stain positive for SA-β-Gal in
vivo, yet again raising interesting discussions regarding
the identification of senescent cells. However, given
that these cells expressmany additional senescencemark-
ers (including p16, p19, p21, and p53) and have lost prolif-
eration markers as well as the fact that it is possible to
undergo senescence without expression of SA-β-Gal (Lee
et al. 2006), it seems reasonable that they can still be de-
scribed as senescent.
Overall, however, our discovery that timely controlled
exposure to the SASP can directly promote tissue regener-
ation identifies important new biological underpinnings
for the senescence program, supporting the idea that sen-
escence is primarily a beneficial and regenerative process.
However, when perturbed, this can have detrimental ef-
fects seen during tumor formation and aging. This also
suggests that a better understanding of the underlying
Figure 7. Schematic diagram illustrating transient and chronic
exposure to SASP. Transient or low-level exposure to the SASP
(dashed arrows) is beneficial, inducing plasticity and regenera-
tion. However, prolonged or chronic exposure to the SASP (solid
arrows) induces increased stemness, which is blocked by para-
crine senescence arrest.
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mechanisms might be harnessed for functional regenera-
tion of tissues and organs.
Materials and methods
Animal use
Wild-type C57Bl6/J, p53–/–, p21–/–, FVB/N, β-Actin GFP reporter,
and Swiss Nudemicewere housed in accordancewith the Ethical
Committee for Animal Experimentation (CEEA) of the Govern-
ment of Catalonia. Papillomas were generated as described previ-
ously (Abel et al. 2009). Briefly, shaved dorsal back skin of seven
to nine w FVB/N female mice was treated with a single dose of
100 nMDMBA (Sigma-Aldrich) and subsequent twice-weekly ap-
plications of 6.8 nM TPA (Sigma-Aldrich) for a period of up to 20
wk.Hair reconstitution assayswere performed as described previ-
ously (Jensen et al. 2010). PanIn lesions were obtained from Pdx1-
Cre; LSL-KrasG12D/+ mice as described in Morton et al. (2010).
To induce senescence in single cells in the liver, transposable
constructs of oncogenic Nras (NrasG12V-IRES-GFP) or an inactive
effector loop mutant of Nras (NrasG12V/D38A-IRES-GFP) were in-
jected into livers as described in Kang et al. (2011).
Tissue culture
Primarymouse keratinocytes and dermal fibroblast cultureswere
established from 1- to 2-d-old mice. Retrovirus was produced by
transiently transfecting the Phoenix packaging cell line (G.
Nolan, Stanford University, Stanford, CA) with MSCV or
HRasV12, and cells were infectedwith virus twice for 2 h, drug-se-
lected in 1 µg/mL puromycin for 48 h, and maintained for up to
another 4–14 d prior to analysis. For double infections, keratino-
cytes were infected three times for 2 h with retrovirus (produced
by transient transfection with HRasV12, MLP, shp16 I, shp16 II,
shRelA I, shRelA II, NFκB superrepressor, shCEBPβ, shIl1α, and
shp38α), drug-selected in 1 µg/mL puromycin for 48 h followed
by a second drug selection in 25 µg/mL hygromycin for 48 h, and
maintained for 6–14 d prior to analysis. Keratinocytes were treat-
ed with 100 nM etoposide (Sigma) for 48 h and then kept in nor-
mal medium or exposed to 12 Gy of irradiation. For proliferation,
BrdU was added to cultured keratinocytes for 16 h, and detection
was performed using a BrdU in situ detection kit (BD Pharmin-
gen) as per themanufacturer’s protocol. SA-β-Gal activity was de-
tected in cultured cells as described previously (Dimri et al. 1995).
Colony-forming assays were performed as described previously
(Jensen et al. 2010). The following sequences of shRNAswere tak-
en from Fellmann et al. (2013): shp16 I (TGCTGTTGACAGT
GAGCGCTGGCATGAGAAACTGAGCGAATAGTGAAGCC
ACAGATGTATTCGCTCAGTTTCTCATGCCATTGCCTAC
TGCCTCGGA), shp16 II (TGCTGTTGACAGTGAGCGCAG
CAGCTCTTCTGCTCAACTATAGTGAAGCCACAGATGTA
TAGTTGAGCAGAAGAGCTGCTATGCCTACTGCCTCGG
A), shCEBPβ (TGCTGTTGACAGTGAGCGCCCGTTTCGAGC
ATTAAAGTGATAGTGAAGCCACAGATGTATCACTTTAA
TGCTCGAAACGGATGCCTACTGCCTCGGA), and shIl1α (T
GCTGTTGACAGTGAGCGCCAGGATGTGGACAAACACT
ATTAGTGAAGCCACAGATGTAATAGTGTTTGTCCACAT
CCTGATGCCTACTGCCTCGGA). Sequences for shRelA I
and shRelA II were obtained from Mirimus, Inc.
Immunohistochemistry and immunofluorescence
Papillomaswere fixed in 4%PFA either overnight or for 10min at
room temperature and washed in PBS, and then tissues were pro-
cessed for paraffin or OCT embedding and hematoxylin and eosin
(H&E) staining. Skin grafts were fixed in 4% PFA for 12 min at
room temperature, washed in PBS, and embedded in OCT, and
60-µm sections were cut. Immunohistochemistry and immuno-
fluorescence analysis was performed using standard procedures.
Antigen retrieval, where necessary, was performed by boiling
deparaffinized sections for 20 min in 0.01 M citric acid buffer
(pH 6.0). Primary antibodies were incubated overnight at 4°C,
and secondary antibodies were incubated for 1 h at room temper-
ature in 1% serum and 0.1%Triton-X in PBS. Sectionswere treat-
ed with streptavidin–biotin–peroxidase (VectaStain Elite, Vector
Laboratories), and immune complexes were visualized with dia-
minobenzidine (Vector Laboratories) as per the manufacturer’s
protocol. The following primary antibodies were used at the indi-
cated dilutions: anti-p16 (1:200; Santa Cruz Biotechnology, M-
156), anti-p16 (1:200; Abcam, 2D9A12), anti-p21 (1:200; BD Phar-
mingen, SXM30), anti-p19ARF (1:200; Abcam, ab80), anti-Ki67
(1:200; Abcam, ab15580), anti-PCNA (1:200; Sigma-Aldrich,
P8824), anti-MCM2 (1:100; Cell Signaling), anti-p53 (1:200; Leica
Microsystems, CM5), anti-P-Histone H2AX (1:200; Cell Signal-
ing, Ser139), anti-CD34 (1:100; eBioscience, RAM34), anti-
CD44 (1:200; Abcam, ab157107), anti-CD44 (1:100; BD Biosci-
ences, 550538), anti-Nestin (1:100; Millipore, MAB353), anti-
GFP (1:200; SantaCruz Biotechnology, B-2), anti-GFP (1:200; Invi-
trogen, A11122), and cleaved Caspase-3 (1:400; Cell Signaling,
9661L). Biotin or Alexa-conjugated secondary antibodies (VectaS-
tain Elite or Molecular Probes) were used at a dilution of 1:2000–
1:500. Representative pictures were acquired with a Leica
DMI 6000Bmicroscope. For SA-β-Gal staining in solid tissue, pre-
malignant lesions whole-mount-stained with SA-β-Gal were
fixed in 4% PFA overnight at 4°C, and 10-µm paraffin sections
were cut.
CM
CM was collected and filtered from MSCV- or HrasV12-infected
primary mouse keratinocytes 7 d post-infection (dpi) or from un-
treated or irradiated keratinocytes 7 d after irradiation and added
to primary mouse keratinocytes every 24 h for up to 6 d. For hair
reconstitution assay, the CM was collected, filtered, and pooled
from primary mouse keratinocytes infected with either MSCV
orHrasV12 at 6–8 dpi and normalized with fresh medium accord-
ing to cell number.
Flow cytometry
Epidermal cells were isolated from the dorsal back skin of adult
C57Bl6/J mice or 1- to 2-d-old mice. Cultured keratinocytes
were isolated through incubation with 0.05% trypsin for 10
min at 37°C followed by inactivation of trypsin by the addition
of DMEM containing 10% serum and centrifugation at 1000
rpm for 7 min. Cell suspensions were incubated for 60 min on
ice with the following antibodies at the indicated dilutions:
APC-conjugated or FITC-conjugated anti-CD34 (1:200; BD Phar-
mingen, clone RAM34), FITC-conjugated anti-α6-integrin (1:200;
Serotec, CD49f clone NKI-GoH3), and APC-conjugated lineage
antibody cocktail (1:200; BD Pharmingen). Keratinocytes were
sorted on the basis of single cellularity, viability (DAPI), and/or
CD34/CD49f status. FACS purification was performed on a
FACSAria systemequippedwith FACSDiVa software (BDBiosci-
ences). FACS analysis was performed using LSRII FACS analyzers
(BD Biosciences) or LSR Fortessa (BD Biosciences) and analyzed
using Flowjo software.
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Microarray analysis
Total RNA was isolated from four separate technical replicates
of primary mouse keratinocytes infected with MSCV and
HRasV12 at 6 dpi using an RNAEasy mini RNA extraction kit
(Qiagen). RNA was subsequently labeled and hybridized to Agi-
lent 8x60 one-color gene expression arrays. Bioinformatics analy-
sis was performed using Genomatix software (Genomatix
Software GmbH). The microarray data have been uploaded to
the Gene Expression Omnibus database with accession number
GSE93564.
Real-time qPCR and analysis
Total RNA from cultured or FACS-sorted cells was purified using
Trizol or an RNAEasy microRNA extraction kit (Qiagen) and re-
verse-transcribed using qScript supermix (Quanta Biosciences).
Real-time qPCR was performed using gene-specific primers
(Supplemental Table 2) and a LightCycler 480 (Roche). qPCR
analysis for vector time-course keratinocytes (Supplemental Fig.
1e) was performed on the following biological replicates: 6 dpi (n
= 12), 8 dpi (n = 10), 10 dpi (n = 9), 12 dpi (n = 8), and 14 dpi (n = 3).
Statistical analysis
Results are presented asmean ± SEM. Statistical significance was
determined by the two-tailed unpaired Student’s t-test.
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